Methylation of N6 adenosine‐related long noncoding RNA: effects on prognosis and treatment in ‘driver‐gene‐negative’ lung adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13323
Abstract: The improvement of treatment for patients with ‘driver‐gene‐negative’ lung adenocarcinoma (LUAD) remains a critical problem to be solved. We aimed to explore the role of methylation of N6 adenosine (m6A)‐related long noncoding RNA (lncRNA) in… read more here.
Keywords: negative lung; gene negative; driver gene; rna ... See more keywords
Whole-genome and transcriptome landscape of actionable driver-negative lung adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.8523
Abstract: 8523 Background: Driver-negative lung adenocarcinoma (DN-LUAD) without actionable genomic alterations (AGAs) has a poor prognosis. A deeper understanding of its molecular background, particularly across the entire genome, is crucial for improving risk assessment and therapeutic… read more here.
Keywords: lung adenocarcinoma; negative lung; driver negative; whole genome ... See more keywords